1 Study Coverage
    1.1 Dermatological Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Dermatological Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Prescription-Based Drugs
        1.2.3 Over-the-Counter Drugs
    1.3 Market by Application
        1.3.1 Global Dermatological Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Dermatological Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Dermatological Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Dermatological Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Dermatological Drugs Sales by Region
        2.4.1 Global Dermatological Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Dermatological Drugs by Region (2023-2028)
    2.5 Global Dermatological Drugs Revenue by Region
        2.5.1 Global Dermatological Drugs Revenue by Region (2017-2022)
        2.5.2 Global Dermatological Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Dermatological Drugs Sales by Manufacturers
        3.1.1 Global Top Dermatological Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Dermatological Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dermatological Drugs in 2021
    3.2 Global Dermatological Drugs Revenue by Manufacturers
        3.2.1 Global Dermatological Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Dermatological Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Dermatological Drugs Revenue in 2021
    3.3 Global Dermatological Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Dermatological Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Dermatological Drugs Sales by Type
        4.1.1 Global Dermatological Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Dermatological Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Dermatological Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Dermatological Drugs Revenue by Type
        4.2.1 Global Dermatological Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Dermatological Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Dermatological Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Dermatological Drugs Price by Type
        4.3.1 Global Dermatological Drugs Price by Type (2017-2022)
        4.3.2 Global Dermatological Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Dermatological Drugs Sales by Application
        5.1.1 Global Dermatological Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Dermatological Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Dermatological Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Dermatological Drugs Revenue by Application
        5.2.1 Global Dermatological Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Dermatological Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Dermatological Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Dermatological Drugs Price by Application
        5.3.1 Global Dermatological Drugs Price by Application (2017-2022)
        5.3.2 Global Dermatological Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Dermatological Drugs Market Size by Type
        6.1.1 North America Dermatological Drugs Sales by Type (2017-2028)
        6.1.2 North America Dermatological Drugs Revenue by Type (2017-2028)
    6.2 North America Dermatological Drugs Market Size by Application
        6.2.1 North America Dermatological Drugs Sales by Application (2017-2028)
        6.2.2 North America Dermatological Drugs Revenue by Application (2017-2028)
    6.3 North America Dermatological Drugs Market Size by Country
        6.3.1 North America Dermatological Drugs Sales by Country (2017-2028)
        6.3.2 North America Dermatological Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Dermatological Drugs Market Size by Type
        7.1.1 Europe Dermatological Drugs Sales by Type (2017-2028)
        7.1.2 Europe Dermatological Drugs Revenue by Type (2017-2028)
    7.2 Europe Dermatological Drugs Market Size by Application
        7.2.1 Europe Dermatological Drugs Sales by Application (2017-2028)
        7.2.2 Europe Dermatological Drugs Revenue by Application (2017-2028)
    7.3 Europe Dermatological Drugs Market Size by Country
        7.3.1 Europe Dermatological Drugs Sales by Country (2017-2028)
        7.3.2 Europe Dermatological Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Dermatological Drugs Market Size by Type
        8.1.1 Asia Pacific Dermatological Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Dermatological Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Dermatological Drugs Market Size by Application
        8.2.1 Asia Pacific Dermatological Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Dermatological Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Dermatological Drugs Market Size by Region
        8.3.1 Asia Pacific Dermatological Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Dermatological Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Dermatological Drugs Market Size by Type
        9.1.1 Latin America Dermatological Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Dermatological Drugs Revenue by Type (2017-2028)
    9.2 Latin America Dermatological Drugs Market Size by Application
        9.2.1 Latin America Dermatological Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Dermatological Drugs Revenue by Application (2017-2028)
    9.3 Latin America Dermatological Drugs Market Size by Country
        9.3.1 Latin America Dermatological Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Dermatological Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Dermatological Drugs Market Size by Type
        10.1.1 Middle East and Africa Dermatological Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Dermatological Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Dermatological Drugs Market Size by Application
        10.2.1 Middle East and Africa Dermatological Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Dermatological Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Dermatological Drugs Market Size by Country
        10.3.1 Middle East and Africa Dermatological Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Dermatological Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Corporation Information
        11.1.2 Johnson & Johnson Overview
        11.1.3 Johnson & Johnson Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Johnson & Johnson Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Johnson & Johnson Recent Developments
    11.2 Merck
        11.2.1 Merck Corporation Information
        11.2.2 Merck Overview
        11.2.3 Merck Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Merck Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Merck Recent Developments
    11.3 Bayer
        11.3.1 Bayer Corporation Information
        11.3.2 Bayer Overview
        11.3.3 Bayer Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bayer Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bayer Recent Developments
    11.4 Mylan Pharmaceuticals
        11.4.1 Mylan Pharmaceuticals Corporation Information
        11.4.2 Mylan Pharmaceuticals Overview
        11.4.3 Mylan Pharmaceuticals Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Mylan Pharmaceuticals Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Mylan Pharmaceuticals Recent Developments
    11.5 Pfizer
        11.5.1 Pfizer Corporation Information
        11.5.2 Pfizer Overview
        11.5.3 Pfizer Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Pfizer Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Pfizer Recent Developments
    11.6 F. Hoffmann-La Roche
        11.6.1 F. Hoffmann-La Roche Corporation Information
        11.6.2 F. Hoffmann-La Roche Overview
        11.6.3 F. Hoffmann-La Roche Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 F. Hoffmann-La Roche Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 F. Hoffmann-La Roche Recent Developments
    11.7 Allergan
        11.7.1 Allergan Corporation Information
        11.7.2 Allergan Overview
        11.7.3 Allergan Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Allergan Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Allergan Recent Developments
    11.8 Valeant Pharmaceuticals
        11.8.1 Valeant Pharmaceuticals Corporation Information
        11.8.2 Valeant Pharmaceuticals Overview
        11.8.3 Valeant Pharmaceuticals Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Valeant Pharmaceuticals Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Valeant Pharmaceuticals Recent Developments
    11.9 PharmaDerm Pharmaceuticals
        11.9.1 PharmaDerm Pharmaceuticals Corporation Information
        11.9.2 PharmaDerm Pharmaceuticals Overview
        11.9.3 PharmaDerm Pharmaceuticals Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 PharmaDerm Pharmaceuticals Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 PharmaDerm Pharmaceuticals Recent Developments
    11.10 Allergan Inamed Corporation
        11.10.1 Allergan Inamed Corporation Corporation Information
        11.10.2 Allergan Inamed Corporation Overview
        11.10.3 Allergan Inamed Corporation Dermatological Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Allergan Inamed Corporation Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Allergan Inamed Corporation Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Dermatological Drugs Industry Chain Analysis
    12.2 Dermatological Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Dermatological Drugs Production Mode & Process
    12.4 Dermatological Drugs Sales and Marketing
        12.4.1 Dermatological Drugs Sales Channels
        12.4.2 Dermatological Drugs Distributors
    12.5 Dermatological Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Dermatological Drugs Industry Trends
    13.2 Dermatological Drugs Market Drivers
    13.3 Dermatological Drugs Market Challenges
    13.4 Dermatological Drugs Market Restraints
14 Key Findings in The Global Dermatological Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Dermatological Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Prescription-Based Drugs
    Table 3. Major Manufacturers of Over-the-Counter Drugs
    Table 4. Global Dermatological Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Dermatological Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Dermatological Drugs Sales by Region (2017-2022) & (MT)
    Table 7. Global Dermatological Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Dermatological Drugs Sales by Region (2023-2028) & (MT)
    Table 9. Global Dermatological Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Dermatological Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Dermatological Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Dermatological Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Dermatological Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Dermatological Drugs Sales by Manufacturers (2017-2022) & (MT)
    Table 15. Global Dermatological Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Dermatological Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Dermatological Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Dermatological Drugs Price by Manufacturers (2017-2022) &(USD/MT)
    Table 19. Global Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Dermatological Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Drugs as of 2021)
    Table 21. Dermatological Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Dermatological Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Dermatological Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Dermatological Drugs Sales by Type (2017-2022) & (MT)
    Table 26. Global Dermatological Drugs Sales by Type (2023-2028) & (MT)
    Table 27. Global Dermatological Drugs Sales Share by Type (2017-2022)
    Table 28. Global Dermatological Drugs Sales Share by Type (2023-2028)
    Table 29. Global Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Dermatological Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Dermatological Drugs Revenue Share by Type (2023-2028)
    Table 33. Dermatological Drugs Price by Type (2017-2022) & (USD/MT)
    Table 34. Global Dermatological Drugs Price Forecast by Type (2023-2028) & (USD/MT)
    Table 35. Global Dermatological Drugs Sales by Application (2017-2022) & (MT)
    Table 36. Global Dermatological Drugs Sales by Application (2023-2028) & (MT)
    Table 37. Global Dermatological Drugs Sales Share by Application (2017-2022)
    Table 38. Global Dermatological Drugs Sales Share by Application (2023-2028)
    Table 39. Global Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Dermatological Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Dermatological Drugs Revenue Share by Application (2023-2028)
    Table 43. Dermatological Drugs Price by Application (2017-2022) & (USD/MT)
    Table 44. Global Dermatological Drugs Price Forecast by Application (2023-2028) & (USD/MT)
    Table 45. North America Dermatological Drugs Sales by Type (2017-2022) & (MT)
    Table 46. North America Dermatological Drugs Sales by Type (2023-2028) & (MT)
    Table 47. North America Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Dermatological Drugs Sales by Application (2017-2022) & (MT)
    Table 50. North America Dermatological Drugs Sales by Application (2023-2028) & (MT)
    Table 51. North America Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Dermatological Drugs Sales by Country (2017-2022) & (MT)
    Table 54. North America Dermatological Drugs Sales by Country (2023-2028) & (MT)
    Table 55. North America Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Dermatological Drugs Sales by Type (2017-2022) & (MT)
    Table 58. Europe Dermatological Drugs Sales by Type (2023-2028) & (MT)
    Table 59. Europe Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Dermatological Drugs Sales by Application (2017-2022) & (MT)
    Table 62. Europe Dermatological Drugs Sales by Application (2023-2028) & (MT)
    Table 63. Europe Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Dermatological Drugs Sales by Country (2017-2022) & (MT)
    Table 66. Europe Dermatological Drugs Sales by Country (2023-2028) & (MT)
    Table 67. Europe Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Dermatological Drugs Sales by Type (2017-2022) & (MT)
    Table 70. Asia Pacific Dermatological Drugs Sales by Type (2023-2028) & (MT)
    Table 71. Asia Pacific Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Dermatological Drugs Sales by Application (2017-2022) & (MT)
    Table 74. Asia Pacific Dermatological Drugs Sales by Application (2023-2028) & (MT)
    Table 75. Asia Pacific Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Dermatological Drugs Sales by Region (2017-2022) & (MT)
    Table 78. Asia Pacific Dermatological Drugs Sales by Region (2023-2028) & (MT)
    Table 79. Asia Pacific Dermatological Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Dermatological Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Dermatological Drugs Sales by Type (2017-2022) & (MT)
    Table 82. Latin America Dermatological Drugs Sales by Type (2023-2028) & (MT)
    Table 83. Latin America Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Dermatological Drugs Sales by Application (2017-2022) & (MT)
    Table 86. Latin America Dermatological Drugs Sales by Application (2023-2028) & (MT)
    Table 87. Latin America Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Dermatological Drugs Sales by Country (2017-2022) & (MT)
    Table 90. Latin America Dermatological Drugs Sales by Country (2023-2028) & (MT)
    Table 91. Latin America Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Dermatological Drugs Sales by Type (2017-2022) & (MT)
    Table 94. Middle East and Africa Dermatological Drugs Sales by Type (2023-2028) & (MT)
    Table 95. Middle East and Africa Dermatological Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Dermatological Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Dermatological Drugs Sales by Application (2017-2022) & (MT)
    Table 98. Middle East and Africa Dermatological Drugs Sales by Application (2023-2028) & (MT)
    Table 99. Middle East and Africa Dermatological Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Dermatological Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Dermatological Drugs Sales by Country (2017-2022) & (MT)
    Table 102. Middle East and Africa Dermatological Drugs Sales by Country (2023-2028) & (MT)
    Table 103. Middle East and Africa Dermatological Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Dermatological Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Johnson & Johnson Corporation Information
    Table 106. Johnson & Johnson Description and Major Businesses
    Table 107. Johnson & Johnson Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 108. Johnson & Johnson Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Johnson & Johnson Recent Developments
    Table 110. Merck Corporation Information
    Table 111. Merck Description and Major Businesses
    Table 112. Merck Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 113. Merck Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Merck Recent Developments
    Table 115. Bayer Corporation Information
    Table 116. Bayer Description and Major Businesses
    Table 117. Bayer Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 118. Bayer Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Bayer Recent Developments
    Table 120. Mylan Pharmaceuticals Corporation Information
    Table 121. Mylan Pharmaceuticals Description and Major Businesses
    Table 122. Mylan Pharmaceuticals Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 123. Mylan Pharmaceuticals Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Mylan Pharmaceuticals Recent Developments
    Table 125. Pfizer Corporation Information
    Table 126. Pfizer Description and Major Businesses
    Table 127. Pfizer Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 128. Pfizer Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Pfizer Recent Developments
    Table 130. F. Hoffmann-La Roche Corporation Information
    Table 131. F. Hoffmann-La Roche Description and Major Businesses
    Table 132. F. Hoffmann-La Roche Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 133. F. Hoffmann-La Roche Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. F. Hoffmann-La Roche Recent Developments
    Table 135. Allergan Corporation Information
    Table 136. Allergan Description and Major Businesses
    Table 137. Allergan Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 138. Allergan Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Allergan Recent Developments
    Table 140. Valeant Pharmaceuticals Corporation Information
    Table 141. Valeant Pharmaceuticals Description and Major Businesses
    Table 142. Valeant Pharmaceuticals Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 143. Valeant Pharmaceuticals Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Valeant Pharmaceuticals Recent Developments
    Table 145. PharmaDerm Pharmaceuticals Corporation Information
    Table 146. PharmaDerm Pharmaceuticals Description and Major Businesses
    Table 147. PharmaDerm Pharmaceuticals Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 148. PharmaDerm Pharmaceuticals Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. PharmaDerm Pharmaceuticals Recent Developments
    Table 150. Allergan Inamed Corporation Corporation Information
    Table 151. Allergan Inamed Corporation Description and Major Businesses
    Table 152. Allergan Inamed Corporation Dermatological Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 153. Allergan Inamed Corporation Dermatological Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Allergan Inamed Corporation Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Dermatological Drugs Distributors List
    Table 158. Dermatological Drugs Customers List
    Table 159. Dermatological Drugs Market Trends
    Table 160. Dermatological Drugs Market Drivers
    Table 161. Dermatological Drugs Market Challenges
    Table 162. Dermatological Drugs Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dermatological Drugs Product Picture
    Figure 3. Global Dermatological Drugs Market Share by Type in 2021 & 2028
    Figure 3. Prescription-Based Drugs Product Picture
    Figure 4. Over-the-Counter Drugs Product Picture
    Figure 5. Global Dermatological Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospital Pharmacies
    Figure 7. Retail Pharmacies
    Figure 8. Online Pharmacies
    Figure 9. Dermatological Drugs Report Years Considered
    Figure 10. Global Dermatological Drugs Sales 2017-2028 (MT)
    Figure 11. Global Dermatological Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Dermatological Drugs Revenue 2017-2028 (US$ Million)
    Figure 13. Global Dermatological Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Dermatological Drugs Sales Market Share by Region (2017-2022)
    Figure 15. Global Dermatological Drugs Sales Market Share by Region (2023-2028)
    Figure 16. North America Dermatological Drugs Sales YoY (2017-2028) & (MT)
    Figure 17. North America Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Dermatological Drugs Sales YoY (2017-2028) & (MT)
    Figure 19. Europe Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Dermatological Drugs Sales YoY (2017-2028) & (MT)
    Figure 21. Asia-Pacific Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Dermatological Drugs Sales YoY (2017-2028) & (MT)
    Figure 23. Latin America Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Dermatological Drugs Sales YoY (2017-2028) & (MT)
    Figure 25. Middle East & Africa Dermatological Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Dermatological Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Dermatological Drugs in the World: Market Share by Dermatological Drugs Revenue in 2021
    Figure 28. Global Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Dermatological Drugs Sales Market Share by Type (2017-2028)
    Figure 30. Global Dermatological Drugs Revenue Market Share by Type (2017-2028)
    Figure 31. Global Dermatological Drugs Sales Market Share by Application (2017-2028)
    Figure 32. Global Dermatological Drugs Revenue Market Share by Application (2017-2028)
    Figure 33. North America Dermatological Drugs Sales Market Share by Type (2017-2028)
    Figure 34. North America Dermatological Drugs Revenue Market Share by Type (2017-2028)
    Figure 35. North America Dermatological Drugs Sales Market Share by Application (2017-2028)
    Figure 36. North America Dermatological Drugs Revenue Market Share by Application (2017-2028)
    Figure 37. North America Dermatological Drugs Sales Share by Country (2017-2028)
    Figure 38. North America Dermatological Drugs Revenue Share by Country (2017-2028)
    Figure 39. U.S. Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Dermatological Drugs Sales Market Share by Type (2017-2028)
    Figure 42. Europe Dermatological Drugs Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Dermatological Drugs Sales Market Share by Application (2017-2028)
    Figure 44. Europe Dermatological Drugs Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Dermatological Drugs Sales Share by Country (2017-2028)
    Figure 46. Europe Dermatological Drugs Revenue Share by Country (2017-2028)
    Figure 47. Germany Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. France Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Dermatological Drugs Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Dermatological Drugs Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Dermatological Drugs Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Dermatological Drugs Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Dermatological Drugs Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Dermatological Drugs Revenue Share by Region (2017-2028)
    Figure 58. China Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. India Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Dermatological Drugs Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Dermatological Drugs Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Dermatological Drugs Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Dermatological Drugs Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Dermatological Drugs Sales Share by Country (2017-2028)
    Figure 73. Latin America Dermatological Drugs Revenue Share by Country (2017-2028)
    Figure 74. Mexico Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Dermatological Drugs Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Dermatological Drugs Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Dermatological Drugs Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Dermatological Drugs Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Dermatological Drugs Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Dermatological Drugs Revenue Share by Country (2017-2028)
    Figure 83. Turkey Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Dermatological Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. Dermatological Drugs Value Chain
    Figure 87. Dermatological Drugs Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed